The first new treatment for malaria for decades receives green light | Americas | North and South American news impact Europe | DW



[ad_1]

The US Food and Drug Administration (FDA) has approved a new single-dose treatment to prevent relapses of one of the most dominant types of malaria.

The new drug, Krintafel, targets only the type of malaria parasite P. vivax, mainly present in South America and Southeast Asia, with about 8.5 million infections per year. Most cases of malaria and death occur in Africa and involve another species.

Read more: The deadly bite of mosquitoes

The British pharmaceutical company GlaxoSmithKline (GSK) and Swiss Medicines for Malaria Venture are developing the drug.

In the tests, a dose of Krintafel had about the same effect as two weeks of standard treatment, preventing relapses in about three quarters of patients over six months, the company said.

Malaria is caused by parasites that spread to humans through mosquito bites. The initial infection can be cured with antimalarial drugs but the parasites can enter the liver and remain dormant, which can cause recurrences months or years later. A second medication is used to stop relapses.

& # 40; A milestone & # 39;

Dr. Hal Barron, Scientific Director and President of Research and Development at GSK, said: "The approval of Krintafel, the first new treatment for Plasmodium vivax malaria for more than 60 years, is a milestone for people affected by this type of recurrent malaria. "

The drug has been approved for patients aged 16 years and over who are receiving appropriate antimalarial treatment for acute P. vivax infection and this is the first new treatment for this type of malaria for more than a year. 60 years old, said GlaxoSmithKline. Read more: Info-film: Our Health and Climate Change

The company will soon apply for homologation in Brazil and then in In other countries where the type of malaria is common, he says he will sell cheap pills in low-income countries.

Malaria infects more than 200 million people worldwide. year and kill about half a million, most of whom are African children.It causes fever, headaches, chills and other flu-like symptoms.

[ad_2]
Source link